Evidence map›Paper›PMID 42702615›Full record

ArticleNature communications2026

Synthetic cargo adaptors reveal molecular features that enhance dynein activation.

Aravintha Siva, John P Gillies, Ashley de Borchgrave, Sharon R Garrott, Rishi Mishra, Rita El Jbeily, Reagan S Clarke, Cameron Conklin, Daytan Gibson, Juliana L Zang and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Aravintha Siva *Department of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
John P Gillies *Department of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Ashley de BorchgraveDepartment of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0009-0003-7306-374X
Sharon R GarrottDepartment of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Rishi MishraDepartment of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Rita El JbeilyDepartment of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Reagan S ClarkeDepartment of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Cameron ConklinDepartment of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0009-0001-2382-4120
Daytan GibsonDepartment of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Juliana L ZangDepartment of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Morgan E DeSantisDepartment of Molecular Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA. mdesant@umich.edu.ORCID http://orcid.org/0000-0002-4096-8548

Funding

Michigan Chemistry-Biology Interface Training ProgramT32GM132046 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Emily E Scott, Wenjing Wang · 2019 to 2026
$4.1M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
Mechanisms of chromosome motility during mammalian meiosisR01HD108809 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jayakrishnan Nandakumar · 2022 to 2026
$2.4M
Mechanisms of dynein regulationR35GM146739 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Morgan DeSantis · 2022 to 2026
$1.7M
Damon Runyon Cancer Research Foundation (Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation) DRG: 2574-26National Science Foundation (NSF) 2142670NICHD NIH HHS R01 HD108809NIGMS NIH HHS R35 GM146739NIGMS NIH HHS T32 GM132046NIGMS NIH HHS T32 GM145304U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R01HD108809U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM146739U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM132046U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM145304
6 · The paper itself

Abstract

Cytoplasmic dynein-1 (dynein) facilitates the microtubule-based retrograde trafficking of all cellular cargo. To become active, dynein binds dynactin and one of many cargo-specific adaptors forming the dynein-dynactin-adaptor transport complex. Despite having similar structures, transport complexes assembled with different adaptors move with different properties in vitro. To explore how adaptors activate dynein, we engineered a library of synthetic adaptors and characterized their ability to activate dynein using in vitro reconstitution and cell-based trafficking assays. We found that dynein motility is highly plastic and tunable by the adaptor, and that it is possible to engineer adaptors that outperform endogenous adaptors' ability to generate highly motile transport complexes. We also found that different adaptors support distinct cellular trafficking behavior and cargo movement. In this study, we provide insight into how dynein motility is modulated to meet the unique trafficking requirements of all cellular cargo.

Indexed as

Dynactin ComplexDyneinsAnimalsHumansMicrotubulesProtein BindingProtein TransportDynactin ComplexDyneins

Identifiers

PMID42702615
PMCPMC13547401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.